These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 3023775

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 4. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW, Gorney B, Cornfeldt M, Fielding S.
    Psychopharmacology (Berl); 1989 Jul; 99(4):492-6. PubMed ID: 2556726
    [Abstract] [Full Text] [Related]

  • 5. Effects of mu- and kappa-opioid receptor agonists on urinary output in mice.
    Rathbun RC, Kattau RW, Leander JD.
    Pharmacol Biochem Behav; 1983 Nov; 19(5):863-6. PubMed ID: 6316374
    [Abstract] [Full Text] [Related]

  • 6. Kappa opioid receptor-mediated analgesia in the developing rat.
    Barr GA, Paredes W, Erickson KL, Zukin RS.
    Brain Res; 1986 Oct; 394(2):145-52. PubMed ID: 3021285
    [Abstract] [Full Text] [Related]

  • 7. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL, Richard JW, Thakur M.
    Life Sci; 1986 Oct; 31(20-21):2313-7. PubMed ID: 6131359
    [Abstract] [Full Text] [Related]

  • 8. Delineation of mu-antagonist, partial kappa agonist and non-opioid agonist activity of cyclazocine using urinary output of rats.
    Leander JD.
    Pharmacol Biochem Behav; 1987 Apr; 26(4):705-7. PubMed ID: 3037567
    [Abstract] [Full Text] [Related]

  • 9. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M, Kubota A, Iwama T, Wada T, Yasui M, Fujibayashi K, Takagi H.
    Life Sci; 1983 Apr; 33 Suppl 1():689-92. PubMed ID: 6141508
    [Abstract] [Full Text] [Related]

  • 10. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat.
    Millan MJ, Morris BJ.
    Brain Res; 1988 May 31; 450(1-2):247-58. PubMed ID: 2841004
    [Abstract] [Full Text] [Related]

  • 11. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar 31; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 12. Kappa opioid agonists and antagonists: effects on drinking and urinary output.
    Leander JD.
    Appetite; 1984 Mar 31; 5(1):7-14. PubMed ID: 6091543
    [Abstract] [Full Text] [Related]

  • 13. Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice.
    Hiramatsu M, Nabeshima T, Kameyama T.
    J Pharmacobiodyn; 1986 May 31; 9(5):466-72. PubMed ID: 3020223
    [Abstract] [Full Text] [Related]

  • 14. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C, Yaksh TL.
    J Pharmacol Exp Ther; 1984 Jan 31; 228(1):1-12. PubMed ID: 6319664
    [Abstract] [Full Text] [Related]

  • 15. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A, Kelly A.
    Eur J Pharmacol; 1985 Apr 16; 110(3):317-22. PubMed ID: 2988982
    [Abstract] [Full Text] [Related]

  • 16. Morphine- and ketocyclazocine-induced analgesia in the developing rat: differences due to type of noxious stimulus and body topography.
    Giordano J, Barr GA.
    Brain Res; 1987 Apr 16; 429(2):247-53. PubMed ID: 3032373
    [Abstract] [Full Text] [Related]

  • 17. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
    Turkish S, Cooper SJ.
    Pharmacol Biochem Behav; 1984 Jul 16; 21(1):47-51. PubMed ID: 6087378
    [Abstract] [Full Text] [Related]

  • 18. Analgesic actions of mu- and kappa-opiate agonists in rats.
    Upton N, Sewell RD, Spencer PS.
    Arch Int Pharmacodyn Ther; 1983 Apr 16; 262(2):199-207. PubMed ID: 6135397
    [Abstract] [Full Text] [Related]

  • 19. Antagonism of the analgesic effects of mu and kappa opioid agonists in the squirrel monkey.
    Dykstra LA, Massie CA.
    J Pharmacol Exp Ther; 1988 Sep 16; 246(3):813-21. PubMed ID: 2843630
    [Abstract] [Full Text] [Related]

  • 20. Further study of kappa opioids on increased urination.
    Leander JD.
    J Pharmacol Exp Ther; 1983 Oct 16; 227(1):35-41. PubMed ID: 6137557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.